PRODUCT CATEGORIES

HS Code : 300210 - Antisera And Other Blood Fractions, And Modified Immunological Products

Previous Category : 3002 - Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products.

Company Name * City / City-State Countries
A**************************** Bogota D.C. Colombia
S***************************************** Distrito Federal Mexico
D******************* Italy Italy
N****************** Santiago Chile
A********************************************** Distrito Federal Mexico
B************************* Philippines Philippines
L************************** BS - BAHAMAS Bahamas
B********************* Uganda Uganda
У************ BY - Belarus Belarus
B*********************** Nigeria Nigeria
K*************** DUNODNALD BELFAST United Kingdom
N************************* Viet Nam Viet Nam
M************************** Bulgaria Bulgaria
C********************************** Switzerland Switzerland
A************************************************ Sri Lanka Sri Lanka
Н********** AM - Armenia Armenia
B******************* Tanzania Tanzania
О************** Georgia Georgia
L**************** GY - Guyana Guyana
B****** United States United States
C******************************** Ve-Venezuela Venezuela
Keywords : Abagovomab , Abatacept , Abciximab , Adalimumab , Adecatumumab , Afelimomab , Aflibercept , Afutuzumab , Alacizumab Pegol , Alefacept , Alemtuzumab , Altumomab , Anatumomab Mafenatox , Ancestim , Animal Blood Albumin , Anrukinzumab , Antisera , Antithrombin Alfa , Apolizumab , Arcitumomab , Aselizumab , Atacicept , Atorolimumab , Baminercept , Bapineuzumab , Basiliximab , Bavituximab , Bectumomab , Belatacept , Belimumab , Benralizumab , Bertilimumab , Besilesomab , Bevacizumab , Binetrakin , Biotechnology Products , Bivatuzumab , Blinatumomab , Blood Fractions , Blood Plasma , Bovine Albumin , Briakinumab , Cantuzumab Mertansine , Catumaxomab , Cedelizumab , Certolizumab Pegol , Cetuximab , Cixutumumab , Clenoliximab , Conatumumab , Dacetuzumab , Dalotuzumab , Daratumumab , Darbepoetin Alfa , Denosumab , Detumomab , Drotrecogin Alfa , Ecromeximab , Eculizumab , Edobacomab , Edodekin Alfa , Edrecolomab , Efalizumab , Efungumab , Elotuzumab , Elsilimomab , Epitumomab , Epitumomab Cituxetan , Epoetin Delta , Epoetin Theta , Epoetin Zeta , Epratuzumab , Erlizumab , Ertumaxomab , Etanercept , Etaracizumab , Exbivirumab , Faralimomab , Farletuzumab , Felvizumab , Fezakinumab , Figitumumab , Fontolizumab , Foravirumab , Fresolimumab , Galiximab , Garnocestim , Gavilimomab , Gemtuzumab , Girentuximab , Glembatumumab , Golimumab , Hemoglobin Glutamer , Hemoglobin Raffimer , Iboctadekin , Ibritumomab Tiuxetan , Ilodecakin , Immunological Products , Immunological Products Modified , Inotuzumab Ozogamicin , Intetumumab , Ipilimumab , Iratumumab , Keliximab , Labetuzumab , Lebrikizumab , Lemalesomab , Lerdelimumab , Lexatumumab , Libivirumab , Lintuzumab , Lucatumumab , Lumiliximab , Mapatumumab , Maslimomab , Matuzumab , Mavrilimumab , Mepolizumab , Metelimumab , Milatuzumab , Minretumomab , Mirostipen , Mitumomab , Modified Immunological Products , Morolimumab , Motavizumab , Moxetumomab Pasudotox , Nacolomab Tafenatox , Natalizumab , Nebacumab , Necitumumab , Nerelimomab , N